ROSELYN TORRES RIERA: Open Payments
NPI 1528591708 · SAINT CLOUD, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,837 in 80 payments from 26 companies in 2025. Trend: 2023 $0 · 2024 $352 · 2025 $1,837
Food & beverage: $1,837
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 12 | $251 |
| SANOFI-AVENTIS U.S. LLC | 7 | $180 |
| Amgen Inc. | 8 | $172 |
| Bayer Healthcare Pharmaceuticals Inc. | 5 | $125 |
| Madrigal Pharmaceuticals | 4 | $118 |
| Ascendis Pharma Endocrinology Inc | 4 | $89 |
| Lilly USA, LLC | 5 | $82 |
| CeQur Corporation | 1 | $71 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 3 | $64 |
| Amneal Pharmaceuticals LLC | 3 | $63 |
Products named: TZIELD, Kerendia, Ozempic, TEPEZZA, REZDIFFRA, JARDIANCE, Yorvipath, CeQur Simplicity.
Industry payments across FL — which companies pay providers there.
